High-Intensity Laser Therapy Versus Shockwave Therapy in Osteoporotic Long Term Hemiparetic Patients - Trial NCT05616611
Access comprehensive clinical trial information for NCT05616611 through Pure Global AI's free database. This phase not specified trial is sponsored by Beni-Suef University and is currently Completed. The study focuses on Osteoporosis Secondary. Target enrollment is 120 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Beni-Suef University
Timeline & Enrollment
N/A
Oct 01, 2021
Mar 01, 2022
Primary Outcome
Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO-41),Pain intensity,fall risk assessment
Summary
Background: The relationship between immobilization and localized osteoporosis is well
 documented in chronic stroke patients. Hemiparetic patients are predisposed to fractures and
 usual activity impairment due to a considerable loss of bone density. A serious health care
 challenge is finding ways to reduce osteoporosis and associated fractures among stroke
 survivors. This study aimed to compare the effects of HILT and ESWT in treating osteoporosis
 and its consequences in hemiparetic patients.
 
 Patients and Methods: A randomized controlled trial was performed at the Faculty of Physical
 Therapy Outpatient Clinic, Cairo University. One hundred and twenty hemiplegic patients with
 osteoporosis of both sexes were chosen randomly. They were randomly classified into three
 equal groups (n=40 in each group). The control group received medication and traditional
 physiotherapy programs for stroke patients (strengthening, stretching, and balance exercise).
 The high-intensity laser (HIL) group received the same intervention as the control group in
 addition to high-intensity laser therapy. The shock wave (SW) group received the same
 intervention as the control group in addition to shock wave therapy. The three groups
 received an intervention that lasted 3 sessions/week for 12 weeks). All groups were assessed
 before and after therapy (3 months) for the degree of pain, which was evaluated by visual
 analog scale (VAS), fall risk assessment (overall stability index and Short Form of Berg
 Balance Scale (SFBBS)), and Quality of Life Questionnaire of the European Foundation for
 Osteoporosis (QUALEFFO-41).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05616611
Non-Device Trial